Gene therapy approaches to enhance endothelial progenitor cell (EPC) homing may augment
cell engraftment to ischemic tissue and lead to a greater therapeutic response. Therefore, …

Coronavirus disease 2019 (COVID-19) has resulted in public health measures and health
care reconfigurations likely to have impact on chronic disease care. We aimed to assess the …

Objectives : This study was designed to compare the efficacy of angiogenic gene delivery
by ultrasound-mediated (UM) destruction of intravenous carrier microbubbles to direct …

Background The COVID-19 pandemic has reduced access to endomyocardial biopsy (EMB)
rejection surveillance in heart transplant (HT) recipients. This study is the first in Canada to …

Background Patients with heart failure (HF) are at the highest risk for hospital readmissions
during the first few weeks after discharge when patients are transitioning from hospital to …

The Fontan circulation has inherent long-term vulnerabilities such that adult Fontan patients
now comprise the largest, most rapidly growing subgroup of adult congenital heart disease …

Over the past few decades, left ventricular assist device (LVAD) support has extended the
lives of many patients with end-stage heart failure. The most common devices are continuous-…

Heart failure with reduced ejection fraction is a clinical syndrome of dysp nea, exercise
intolerance and/or edema resulting from an impairment of ejec tion of blood, usually documented …

… Author links open overlay panel Jeremy Kobulnik MD a b c , Irene-Yanran Wang MSc b ,
Chaim … Jeremy Kobulnik has received an honorarium for participating in an advisory board for …

Over the past 5 years, researchers have examined the utility of many experimental heart
failure biomarkers that are not yet widely adopted clinically, to complement the role of B-type …